Oral and Parenteral Glutamine in Bone Marrow Transplantation: A Randomized, Double‐Blind Study

Abstract

Oral and parenteral GLN seemed to be of limited benefit for patients having AUTO or ALLO BMT for hematologic or solid malignancies. Further study of long-term effects of GLN in BMT seems warranted.